Neuphoria Therapeutics (NEUP) Interest & Investment Income (2023 - 2026)
Neuphoria Therapeutics (NEUP) reported Interest & Investment Income of $170,093 for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 95.4% from $87,046 a year earlier but down 8.6% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Interest & Investment Income (2023 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Neuphoria Therapeutics posted Interest & Investment Income of $665,571, up 299.7% from FY2025.
- Interest & Investment Income has a three-year compound annual growth rate of 27.2% (FY2023 to FY2026).
- By fiscal year, Interest & Investment Income came in at $166,498 in FY2025 (-24.4%), $220,097 in FY2024 (-31.9%) and $323,158 in FY2023.
- Five-year quarterly Interest & Investment Income spans a low of $12,741 in fiscal Q3 2025 and a high of $186,171 in fiscal Q3 2026.
- Year over year, Interest & Investment Income gained in four of the last seven quarters, with growth averaging 126.8%.
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $186,171 (Q3 2026), $167,311 (Q2 2026) and $141,996 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Neuphoria Therapeutics | 431.33 Mn | 356.14 Mn | - | 170,093.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 170,093.00 |
| Mar 31, 2026 | 186,171.00 |
| Dec 31, 2025 | 167,311.00 |
| Sep 30, 2025 | 141,996.00 |
| Jun 30, 2025 | 87,046.00 |
| Mar 31, 2025 | 12,741.00 |
| Dec 31, 2024 | 30,615.00 |
| Sep 30, 2024 | 36,096.00 |
| Jun 30, 2024 | 26,327.00 |
| Mar 31, 2024 | 52,615.00 |
| Dec 31, 2023 | 54,716.00 |
| Sep 30, 2023 | 86,439.00 |
API Access
Neuphoria Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();